Annual Revenue
$285.71 M
+$24.96 M+9.57%
December 31, 2022
Summary
- As of February 10, 2025, ICPT annual revenue is $285.71 million, with the most recent change of +$24.96 million (+9.57%) on December 31, 2022.
- During the last 3 years, ICPT annual revenue has risen by +$33.71 million (+13.38%).
Performance
ICPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$88.79 M
+$5.07 M+6.06%
September 30, 2023
Summary
- As of February 10, 2025, ICPT quarterly revenue is $88.79 million, with the most recent change of +$5.07 million (+6.06%) on September 30, 2023.
- Over the past year, ICPT quarterly revenue has increased by +$11.20 million (+14.44%).
Performance
ICPT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$317.68 M
+$11.20 M+3.65%
September 30, 2023
Summary
- As of February 10, 2025, ICPT TTM revenue is $317.68 million, with the most recent change of +$11.20 million (+3.65%) on September 30, 2023.
- Over the past year, ICPT TTM revenue has increased by +$40.56 million (+14.64%).
Performance
ICPT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ICPT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.6% | +14.4% | +14.6% |
| 3 y3 years | +13.4% | +11.7% | +5.6% |
| 5 y5 years | +118.2% | +89.0% | +26.1% |
ICPT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -8.7% | at high | -33.4% | at high | -17.3% |
| 5 y | 5-year | at high | -18.1% | at high | -94.9% | at high | -30.4% |
| alltime | all time | at high | -99.4% | at high | -99.5% | at high | -99.8% |
Intercept Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $88.79 M(+6.1%) | $317.68 M(+3.7%) |
| Jun 2023 | - | $83.72 M(+23.2%) | $306.48 M(+4.1%) |
| Mar 2023 | - | $67.96 M(-12.0%) | $294.52 M(+3.1%) |
| Dec 2022 | $285.71 M(+9.6%) | $77.22 M(-0.5%) | $285.71 M(+3.1%) |
| Sep 2022 | - | $77.59 M(+8.1%) | $277.12 M(+4.1%) |
| Jun 2022 | - | $71.76 M(+21.3%) | $266.18 M(+1.4%) |
| Mar 2022 | - | $59.15 M(-13.8%) | $262.60 M(-7.9%) |
| Dec 2021 | $260.75 M(+11.4%) | $68.63 M(+3.0%) | $285.11 M(+29.0%) |
| Sep 2021 | - | $66.64 M(-2.3%) | $221.03 M(-5.5%) |
| Jun 2021 | - | $68.18 M(-16.5%) | $233.91 M(-3.7%) |
| Mar 2021 | - | $81.66 M(+1695.5%) | $242.98 M(+3.9%) |
| Dec 2020 | $233.97 M(-7.2%) | $4.55 M(-94.3%) | $233.97 M(-22.2%) |
| Sep 2020 | - | $79.52 M(+2.9%) | $300.92 M(+6.2%) |
| Jun 2020 | - | $77.25 M(+6.3%) | $283.35 M(+4.0%) |
| Mar 2020 | - | $72.65 M(+1.6%) | $272.40 M(+8.1%) |
| Dec 2019 | $252.00 M(+40.2%) | $71.50 M(+15.4%) | $252.00 M(+7.8%) |
| Sep 2019 | - | $61.95 M(-6.6%) | $233.78 M(+6.8%) |
| Jun 2019 | - | $66.30 M(+26.9%) | $218.82 M(+11.6%) |
| Mar 2019 | - | $52.25 M(-1.9%) | $196.09 M(+9.1%) |
| Dec 2018 | $179.80 M(+37.3%) | $53.28 M(+13.4%) | $179.80 M(+9.5%) |
| Sep 2018 | - | $46.99 M(+7.8%) | $164.21 M(+3.6%) |
| Jun 2018 | - | $43.58 M(+21.2%) | $158.56 M(+8.7%) |
| Mar 2018 | - | $35.96 M(-4.6%) | $145.87 M(+11.4%) |
| Dec 2017 | $130.96 M | $37.69 M(-8.8%) | $130.96 M(+22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $41.33 M(+33.8%) | $107.08 M(+51.0%) |
| Jun 2017 | - | $30.89 M(+46.7%) | $70.92 M(+55.7%) |
| Mar 2017 | - | $21.05 M(+52.4%) | $45.55 M(+82.6%) |
| Dec 2016 | $24.95 M(+796.9%) | $13.81 M(+166.7%) | $24.95 M(+115.3%) |
| Sep 2016 | - | $5.18 M(-6.2%) | $11.59 M(+69.0%) |
| Jun 2016 | - | $5.52 M(+1140.4%) | $6.86 M(+285.0%) |
| Mar 2016 | - | $445.00 K(-0.2%) | $1.78 M(-36.0%) |
| Dec 2015 | $2.78 M(+59.7%) | $446.00 K(+0.2%) | $2.78 M(0.0%) |
| Sep 2015 | - | $445.00 K(0.0%) | $2.78 M(0.0%) |
| Jun 2015 | - | $445.00 K(-69.2%) | $2.78 M(0.0%) |
| Mar 2015 | - | $1.45 M(+224.0%) | $2.78 M(+59.7%) |
| Dec 2014 | $1.74 M(+7.4%) | $446.00 K(+0.2%) | $1.74 M(+2.4%) |
| Sep 2014 | - | $445.00 K(0.0%) | $1.70 M(+2.4%) |
| Jun 2014 | - | $445.00 K(+9.8%) | $1.66 M(+2.4%) |
| Mar 2014 | - | $405.40 K(-0.1%) | $1.62 M(0.0%) |
| Dec 2013 | $1.62 M(-33.7%) | $405.80 K(+0.1%) | $1.62 M(+0.0%) |
| Sep 2013 | - | $405.40 K(0.0%) | $1.62 M(-6.8%) |
| Jun 2013 | - | $405.40 K(0.0%) | $1.74 M(-16.9%) |
| Mar 2013 | - | $405.40 K(0.0%) | $2.09 M(-14.4%) |
| Dec 2012 | $2.45 M(+35.5%) | $405.40 K(-22.5%) | $2.45 M(-12.6%) |
| Sep 2012 | - | $523.20 K(-31.0%) | $2.80 M(-4.0%) |
| Jun 2012 | - | $758.80 K(0.0%) | $2.92 M(+35.2%) |
| Mar 2012 | - | $758.80 K(0.0%) | $2.16 M(+54.2%) |
| Dec 2011 | $1.81 M | $758.80 K(+18.4%) | $1.40 M(+118.4%) |
| Sep 2011 | - | $641.00 K | $641.00 K |
FAQ
- What is Intercept Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual revenue year-on-year change?
- What is Intercept Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly revenue year-on-year change?
- What is Intercept Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM revenue year-on-year change?
What is Intercept Pharmaceuticals annual revenue?
The current annual revenue of ICPT is $285.71 M
What is the all time high annual revenue for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual revenue is $285.71 M
What is Intercept Pharmaceuticals annual revenue year-on-year change?
Over the past year, ICPT annual revenue has changed by +$24.96 M (+9.57%)
What is Intercept Pharmaceuticals quarterly revenue?
The current quarterly revenue of ICPT is $88.79 M
What is the all time high quarterly revenue for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly revenue is $88.79 M
What is Intercept Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, ICPT quarterly revenue has changed by +$11.20 M (+14.44%)
What is Intercept Pharmaceuticals TTM revenue?
The current TTM revenue of ICPT is $317.68 M
What is the all time high TTM revenue for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM revenue is $317.68 M
What is Intercept Pharmaceuticals TTM revenue year-on-year change?
Over the past year, ICPT TTM revenue has changed by +$40.56 M (+14.64%)